Smith+Nephew Sees Better Ortho Performance to Start 2023

Smith+Nephew reported 1Q23 orthopedic sales of $940 million, +2.6% compared to the first quarter of 2022.

The company benefitted from strong elective procedure volumes in the U.S. and Europe, which offset continued headwinds in China. The orthopedics franchise performed better with improved commercial execution and product availability....

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us